421
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China

, , , , &
Pages 1049-1060 | Received 04 Sep 2019, Accepted 21 Jul 2020, Published online: 10 Aug 2020

References

  • He Z, Zhang L, Zhou D. Current situation of overseas research on pharmacoeconomics and existing problems in its application at home. China Pharm. 2001;12(12):4–6.
  • Jakovljevic M, Vukovic M, Chen CC, et al. Do health reforms impact cost consciousness of health care professionals? Results from a nation-wide survey in the Balkans. Balkan Med J. 2016;33(1):8–17.
  • Dieleman JL, Campbell M, Chapin A, et al. Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017;389(10083):2005–2030.
  • Jakovljevic M, Potapchik E, Popovich L, et al. Evolving health expenditure landscape of the BRICS nations and projections to 2025. Health Econ. 2017;26(7):844–852.
  • Jakovljevic M, Getzen TE. Growth of global health spending share in low and middle income countries. Front Pharmacol. 2016;7:21.
  • Jakovljevic M, Fernandes PO, Teixeira JP, et al. Underlying differences in health spending within the World Health Organisation Europe Region—comparing EU15, EU post-2004, CIS, EU candidate, and CARINFONET countries. Int J Environ Res Public Health. 2019;16(17):3043.
  • Jakovljevic M, Jakab M, Gerdtham U, et al. Comparative financing analysis and political economy of noncommunicable diseases. J Med Econ. 2019;22(8):722–727.
  • Doherty J, Kamae I, Lee KK, et al. What is next for pharmacoeconomics and outcomes research in Asia? Value Health. 2004;7(2):118–132.
  • Liu SH, Chuang WC, Lam W, et al., Safety surveillance of traditional Chinese medicine: current and future. Drug Saf. 2015;38(2):117–128.
  • Wang X, Wang ZF, Xie YM, et al. Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation. Chin J Integr Med. 2015;21(6):473–480.
  • Sculpher MJ, Claxton K, Stoddat GL, et al. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.
  • Chen W. Introduction of Pharmacoeconomics. Chin J Med Guide. 2000;3:45–47.
  • Johanna MD, Mohamed EA, Anita NV. What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations? Expert Rev Pharmacoecon Outcomes Res. 2020;20(1):27–37.
  • Ofman JJ, Sullivan SD, Neumann PJ, et al., Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003;9(1):53–61.
  • Tan B, Wu FR, Kang QQ, et al. Different Chinese patent medicine injections as adjunctive therapy for liver cancer: an efficacy and pharmacoeconomic evaluation. Eval Anal Drug Use Hospitals China. 2013;13(6):494–496.
  • Husereau D, Drummond M, Petrou S, et al., Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care. 2013;29(2):117–122.
  • Evers S, Goossens M, De VH, et al., Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria. Int J Technol Assess Health Care. 2005;21(2):240–245.
  • Drummond MF, Richardson WS, O’Brien BJ, et al. Users’ guides to the medical literature, XIII: how to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-based Medicine Working Group. JAMA. 1997;277(19):1552–1557.
  • Pandey P, Pandey RD, Shah V. Evaluation of quality of pharmacoeconomic studies in Asia-Pacific region and identification of influencing variables. Value Health Reg Issues. 2018;15(7):70–75.
  • Vernon E, Hiedemann B, Bowie BH. Economic evaluations of thrombophilia screening prior to prescribing combined oral contraceptives: A systematic and critical review. Appl Health Econ Health Policy. 2017;15(5):583–595.
  • Mangham-Jefferies L, Pitt C, Cousens S, et al. Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth. 2014;14:243.
  • Ma H, Jian W, Xu T, et al. Quality of pharmacoeconomic research in China: a systematic review. Medicine (Baltimore). 2016;95(41):e5114.
  • Tran BX, Nong VM, Maher RM, et al. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One. 2014;9(8):e103825.
  • Yang L, Hu SL. Health outcome measurement in pharmacoeconomic evaluation. China Pharm. 2004;15(2):91–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.